Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas

被引:0
作者
Ilan Shimon
Ernesto Sosa
Victoria Mendoza
Yona Greenman
Amit Tirosh
Etual Espinosa
Vera Popovic
Andrea Glezer
Marcello D. Bronstein
Moises Mercado
机构
[1] Rabin Medical Center,Institute of Endocrinology, Beilinson Hospital
[2] Tel Aviv University,Sackler Faculty of Medicine
[3] IMSS,Endocrinology Service, Hospital de Especialidades, Centro Médico Nacional S.XXI
[4] Tel Aviv-Sourasky Medical Center,Institute of Endocrinology, Metabolism and Hypertension
[5] University of Belgrade,Neuroendocrine Unit, Division of Endocrinology and Metabolism, Hospital das Clínicas
[6] School of Medicine,Experimental Endocrinology Unit, Hospital de Especialidades, Centro Médico Nacional S.XXI
[7] University of São Paulo Medical School,undefined
[8] IMSS,undefined
来源
Pituitary | 2016年 / 19卷
关键词
Cabergoline; Giant; Pituitary adenoma; Prolactin; Prolactinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:429 / 436
页数:7
相关论文
共 69 条
  • [1] Colao A(2003)Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia Eur J Endocrinol 148 325-331
  • [2] Sarno AD(2006)Advances in the treatment of prolactinomas Endocr Rev 27 485-534
  • [3] Cappabianca P(2014)Therapy of endocrine disease: the challenges in managing giant prolactinomas Eur. J. Endocrinol. 170 R 213-227
  • [4] Briganti F(2002)Giant prolactinomas: clinical management and long-term follow up J Neurosurg 97 299-306
  • [5] Pivonello R(2003)Giant prolactinomas in men: efficacy of cabergoline treatment Clin Endocrinol (Oxf) 58 662-670
  • [6] Somma CD(2007)Effectiveness of long-term cabergoline treatment for giant prolactinomas: study of 12 men Eur J Endocrinol 156 225-231
  • [7] Faggiano A(2013)Giant prolactinomas in women Eur J Endocrinol 170 31-38
  • [8] Biondi B(2011)Unusual clinical presentations of giant prolactinomas Pituitary 14 340-344
  • [9] Lombardi G(1992)Treatment of extensively invasive (giant) prolactinomas with bromocriptine N Z Med J 105 129-131
  • [10] Gillman MP(2004)Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis J Clin Endocrinol Metab 89 1704-1711